![](https://ml.globenewswire.com/media/a24f6aa8-4e46-4fb8-85fc-ef0ce4548722/small/evok-logo-jpg.jpg)
Evoke Resubmits Gimoti™ New Drug Application to FDA
SOLANA BEACH, Calif., Dec. 20, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it has resubmitted its 505(b)(2) New Drug …